Hemin ( DrugBank: Hemin )


1 disease
IDDisease name (Link within this page)Number of trials
254Porphyria2

254. Porphyria


Clinical trials : 72 Drugs : 53 - (DrugBank : 16) / Drug target genes : 19 - Drug target pathways : 35
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02922413
(ClinicalTrials.gov)
October 30, 20151/1/2016Panhematin for Prevention of Acute Attacks of PorphyriaSafety and Efficacy of Panhematin™ for Prevention of Acute Attacks of PorphyriaAcute Intermittent Porphyria;Hereditary Coproporphyria;Variegate PorphyriaBiological: Hemin for injection;Other: PlaceboThe University of Texas Medical Branch, GalvestonNULLRecruiting18 YearsN/AAll20Phase 2United States
2NCT02935400
(ClinicalTrials.gov)
April 28, 201413/10/2016Acute Porphyria Biomarkers for Disease ActivityAcute Porphyrias: Biomarkers for Disease Activity and Response to TreatmentAcute Intermittent Porphyria;Hereditary Coproporphyria;Variegate PorphyriaDrug: HeminThe University of Texas Medical Branch, GalvestonNULLActive, not recruiting18 YearsN/AAll50United States